A bipartisan group of House lawmakers is urging the US health department to examine the implementation of the government’s drug price negotiation program and its effects on pharmacies.
The current implementation pathway for the Medicare Drug Price Negotiation Program is unsustainable for pharmacies by forcing them to purchase drugs at higher prices and then wait to be paid back and made whole again, 26 lawmakers said in a letter sent Tuesday to Health and Human Services Secretary Robert F. Kennedy Jr. and Mehmet Oz, administrator for the Centers for Medicare & Medicaid Services.
The drug price program gives the US ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.